Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age... American Journal of Clinical Dermatology https://doi.org/10.1007/s40257-023-00784-6 PUBLISHER CORREC TION Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate‑to‑Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials 1 2,3 4 5 6 Jonathan I. Silverberg  · Charles W. Lynde  · Katrina Abuabara  · Cataldo Patruno  · Anna de Benedetto  · 7 7 8 7 9 Haixin Zhang  · Ryan B. Thomas  · Gaëlle Bégo‑Le‑Bagousse  · Faisal A. Khokhar  · Jignesh Vakil  · 10 7 Ainara Rodríguez Marco  · Noah A. Levit Accepted: 14 April 2023 © Springer Nature Switzerland AG 2023 Publisher Correction to: IGA 0/1 for dupilumab: 44%. American Journal of Clinical Dermatology https:// doi. org/ 10. 1007/ s40257- 022- 00754-4 IGA 0/1 for placebo: 7%. EASI-75 for placebo: 14%. The Original Article was published online on 20 February 2023. The original article has been corrected. As a result of a publisher error, three percentage symbols were missing in the Graphical Abstract on page 2. The val- Open Access This article is licensed under a Creative Commons Attri- ues (with percentage symbols) should read: bution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Clinical Dermatology Springer Journals

Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

Abstract

American Journal of Clinical Dermatology https://doi.org/10.1007/s40257-023-00784-6 PUBLISHER CORREC TION Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate‑to‑Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials 1 2,3 4 5 6 Jonathan I. Silverberg  · Charles W. Lynde  · Katrina Abuabara  ·...
Loading next page...
 
/lp/springer-journals/publisher-correction-to-efficacy-and-safety-of-dupilumab-maintained-in-ZvuWP2f8w9

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Switzerland AG 2023
ISSN
1175-0561
eISSN
1179-1888
DOI
10.1007/s40257-023-00784-6
Publisher site
See Article on Publisher Site

Abstract

American Journal of Clinical Dermatology https://doi.org/10.1007/s40257-023-00784-6 PUBLISHER CORREC TION Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate‑to‑Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials 1 2,3 4 5 6 Jonathan I. Silverberg  · Charles W. Lynde  · Katrina Abuabara  · Cataldo Patruno  · Anna de Benedetto  · 7 7 8 7 9 Haixin Zhang  · Ryan B. Thomas  · Gaëlle Bégo‑Le‑Bagousse  · Faisal A. Khokhar  · Jignesh Vakil  · 10 7 Ainara Rodríguez Marco  · Noah A. Levit Accepted: 14 April 2023 © Springer Nature Switzerland AG 2023 Publisher Correction to: IGA 0/1 for dupilumab: 44%. American Journal of Clinical Dermatology https:// doi. org/ 10. 1007/ s40257- 022- 00754-4 IGA 0/1 for placebo: 7%. EASI-75 for placebo: 14%. The Original Article was published online on 20 February 2023. The original article has been corrected. As a result of a publisher error, three percentage symbols were missing in the Graphical Abstract on page 2. The val- Open Access This article is licensed under a Creative Commons Attri- ues (with percentage symbols) should read: bution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative

Journal

American Journal of Clinical DermatologySpringer Journals

Published: Jul 1, 2023

There are no references for this article.